VC Firm OrbiMed Advisors Raises $325 Million For Second Asia Healthcare Fund

Published: Sep 10, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OrbiMed Advisors has secured $325 million to fund health-care companies in Asian nations such as China and India, where rising affluence is fueling increased demand for medical products and services.

The New York firm set out to raise $300 million for OrbiMed Asia Partners II LP in the first quarter of 2013. The new partnership, which closed over the summer, is a jump from the $182 million OrbiMed raised for its debut Asia fund in 2008.

Help employers find you! Check out all the jobs and post your resume.

Back to news